Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 82.12$. Average daily volumn in 3 months 6.25M. Market cap 103.61B

Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD
Lastest price : 82.97$. Total volume : 7.14M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Gilead Sciences, Inc. (GILD)
Last Price

Previous Close81.45
Day Range81.19-83.14
Bid82.86 x 1.1k
Ask83.00 x 900
Average Volume6.25M
Market Cap103.61B
52 Week Range57.17-89.74
Trailing P/E22.79
Foward P/E11.49
Dividend (Yield %)3.62%
Ex-Dividend Date2023-03-14

Financial Details

According to Gilead Sciences, Inc.'s financial reports the company's revenue in 2022 were 27.28B an decrease(0%) over the years 2021 revenue that were of 27.3B. In 2022 the company's total earnings were 4.59B while total earnings in 2021 were 6.22B(-33.33%).

Loading ...


Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of vi... ral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Market Cap:
Total Assets:
Total Cash:

News about "Gilead Sciences, Inc."

Is Gilead Sciences, Inc.'s (NASDAQ:GILD) 22% ROE Strong Compared To Its Industry?

Source from : YAHOO!Finance - 8 hours ago

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...See details»

Gilead Sciences Inc. (NASDAQ:GILD) Jumps 1.87%, But Additional Rally May Be Imminent

Source from : marketingsentinel - 1 days ago

In last trading session, Gilead Sciences Inc. (NASDAQ:GILD) saw 7.13 million shares changing hands with its beta currently measuring 0.40. Companyโ€™s recent per share price level of $82.97 trading at ...See details»


Gilead Sciences Inc. stock outperforms market on strong trading day

Source from : MarketWatch - 4 days ago

Shares of Gilead Sciences Inc. advanced 1.75% to $80.97 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the ...See details»

Gilead Sciences

Source from : CSR Wire - 3 days ago

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform ...See details»

GILD Gilead Sciences, Inc.

Source from : Seeking Alpha - 2 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»

Gilead Sciences Inc. (GILD) Stock: What the Analysts are Saying

Source from : newsheater - 9 days ago

Gilead Sciences Inc. (NASDAQ: GILD) has a price-to-earnings ratio that is above its average at 21.65x. and a 36-month beta value of 0.40. Opinions on the stock are mixed, with 9 analysts rating it as ...See details»

Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%

Source from : Yahoo Finance - 21 days ago

We note that hedge funds don't have a meaningful investment in Gilead Sciences. BlackRock, Inc. is currently the company's largest shareholder with 11% of shares outstanding. For context ...See details»

Gilead Sciences Inc. (GILD) Stock: A Guide to the Market Trend

Source from : newsheater - 12 days ago

The stock of Gilead Sciences Inc. (GILD) has seen a -0.06% decrease in the past week, with a -4.71% drop in the past month, and a -8.22% decrease in the past quarter. The volatility ratio for the week ...See details»

Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors

Source from : MarketWatch - 17 days ago

Shares of Gilead Sciences Inc. GILD slid 0.15% to $79.65 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.70% to 3,891. ...See details»

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Could Be 40% Below Their Intrinsic Value Estimate

Source from : Yahoo - 3 month ago

Today we will run through one way of estimating the intrinsic value of Gilead Sciences, Inc. (NASDAQ:GILD) by taking the expected future cash flows and discounting them to today's value.See details»

What Contributed to Gilead Sciences (GILD)โ€™s Outperformance in Q4?

Source from : Yahoo - 27 days ago

ClearBridge Sustainability Leaders Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD) in the Q4 2022 investor letter. Headquartered in Foster City, California, Gilead Sciences ...See details»

Gilead Sciences Inc

Source from : Reuters - 17 days ago

2023 Future of Healthcategory GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill, article with image February 22, 2023 Worldcategory Britain's NICE to speed ...See details»

Gilead Sciences, Inc.

Source from : Fierce Healthcare - 1 month ago

For 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Gilead researchers have developed 12 HIV medications ...See details»

Gilead Sciences Inc. News

Source from : - 6 days ago

Add this cloud software stock to your watch list, but it may be a good time to take some profit in this biotech stock and industrial stock.See details»